Due to the differences in breast cancer cell lines with different molecular subtypes, three breast cancer cell lines were used to detect CLDN6 expression under hypoxia (MDA-MB-231: basal-like; MCF-7: luminal A; and SkBr-3: HER2+). This evidence concerns the gene ERBB2 and breast carcinoma.